{"transactions":[{"id":2785888,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-2 Preferred Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":3615656,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":361566},"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785887,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":2544425,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":254442},"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785886,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":25000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The shares of the Issuer's Series C Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of the Issuer's Series C Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of the Issuer's Series C Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of the Issuer's Series C Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785885,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":12000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785884,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":false,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785883,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":361566,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The shares of the Issuer's Series D-2 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":5008508,"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785882,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":254442,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The shares of the Issuer's Series D-1 Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":4646942,"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785881,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":2500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares of the Issuer's Series C Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":4392500,"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785880,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":1200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":1892500,"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":2785879,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-16T21:53:28.000Z","date":"2021-03-16","kind":"exercise","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Series A Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering."}],"balance_after":692500,"source":{"system":"sec-edgar","filing":"0001209191-21-021223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269910/000120919121021223/doc4.xml","form_type":"4"}},{"id":4325090,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-05-12T00:56:53.000Z","date":"2017-05-09","kind":"purchase","acquired":true,"shares":1145161,"price":3.1,"value":3549999.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the \"Issuer\") pursuant to which the Reporting Person, on May 5, 2017  purchased an aggregate of 1,145,161 shares of the Issuer's common stock at a purchase price of $3.10 per share for total cash proceeds of approximately US$3,550,000."}],"balance_after":4049959,"source":{"system":"sec-edgar","filing":"0001144204-17-026585","document":"v466675_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420417026585/v466675_4.xml","form_type":"4"}},{"id":4597340,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":141263,"kind":"person","name":"CEDARS SINAI MEDICAL CENTER","position":1,"cik":"0001269910","reported_name":"CEDARS SINAI MEDICAL CENTER","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-09-23T01:10:10.000Z","date":"2016-09-21","kind":"purchase","acquired":true,"shares":312500,"price":3.2,"value":1000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the \"Issuer\") pursuant to which the Reporting Person, on September 21, 2015, purchased an aggregate of 312,500 shares of the Issuer's common stock at a purchase price of $3.20 per share for total cash proceeds of approximately US$1,000,000."}],"balance_after":2904798,"source":{"system":"sec-edgar","filing":"0001144204-16-124964","document":"v449260_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000114420416124964/v449260_4.xml","form_type":"4"}}]}